Use of moxonidine in elderly patients with resistant hypertension

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 5, 2005, Pages 433-437

  Martin, U ^a,c   Hill, C ^a   O'Mahony, D ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b University College Cork and INFANT Centre   (Ireland)

^c Medical School   (United Kingdom)

Author keywords

Elderly; Hypertension; I1 imidazoline receptor; Moxonidine

Indexed keywords

MOXONIDINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; FEMALE; HUMAN; HYPERTENSION; MALE; OSCILLOMETRY; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CIRCADIAN RHYTHM; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HEART RATE; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; MIDDLE AGED;

EID: 27744592246     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2005.00672.x     Document Type: Article

References (20)

1. Colhoun HM, Dong W, Poulter NR (1998) Blood pressure screening, management and control in England, results from the health survey for England 1994. Journal of Hypertension, 16, 942-946.
2. Lever AF, Ramsey LE (1995) Treatment of hypertension in the elderly. Journal of Hypertension, 13, 571-579.
3. MacMahon S, Rodgers A (1993) The effects of blood pressure reduction in older patients: an overview of five randomised controlled trials in elderly hypertensives. Clinical and Experimental Hypertension, 15, 967-978.
4. Kostis JB, Davis BR, Cutler J et al, for the SHEP Cooperative Research Group. (1997) Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA, 278, 212-216.
5. Forette F, Seux ML, Staessen JA et al. (1998) Prevention of dementia in randomised placebo controlled systolic hypertension in Europe (SystEur) trial. Lancet, 352, 1347-1357.
6. Sanderson S (1996) Hypertension in the elderly: pressure to treat? Health Trends, 28, 71-75.
7. Ramsey LE, Williams B, Johnston GD et al. (1999) Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. Journal of Human Hypertension, 13, 569-592.
8. Prisant LM, Moser M (2000) Hypertension in the Elderly. Archives of Internal Medicine, 160, 283-289.
9. Lanfranchi A, Spaziani D, Seravalle G et al. (1998) Symmpathetic control of circulation in hypertension and congestive cardiac failure. Blood Pressure, (Suppl. 3), 40-15.
10. 1-Imidazoline receptors in the rostral ventrolateral medulla. Journal of Cardiovascular Pharmacology, 24(Suppl. 1), S1-S8.
11. Reis DJ (1992) Neurons and receptors in the rostroventrolateral medulla mediating the anti-hypertensive actions of drugs acting at imidazoline receptors. Journal of Cardiovascular Pharmacology, 20(Suppl. 4), S11-S18.
12. Mitrovic V, Patyna W, Huting J, Schlepper W (1991) Haemodynamic and neurohumoral effects of moxonidine in patients with essential hypertension. Cardiovascular Drugs and Therapy, 5, 967-972.
13. Krentz AJ, Evans AJ (1998) Selective imidazoline receptor agonists for metabolic syndrome. Lancet, 351, 152-153.
14. Chrisp P, Faulds D (1992) Moxonidine. A review of its pharmacology and therapeutic use in essential hypertension. Drugs, 44, 993-1012.
15. Schachter M (1999) Moxonidine: a review of safety and tolerability after seven years experience. Journal of Hypertension, 17(Suppl. 3), S37-S39.
16. 1 imidazoline agonists. General Clinical Pharmacology of imidazoline receptors: implications for the treatment of the elderly. Drugs and Ageing, 17, 133-159.
17. Weimann H-J, Rudolph M (1992) Clinical pharmocokinetics of moxonidine. Journal of Cardiovascular Pharmacology, 20(Suppl. 4), S37-S41.
18. Messerli F (2000) Moxonidine: a new and versatile antihypertensive. Journal of Cardiovascular Pharmacology, 35(Suppl. 4), S53-S56.
19. Morris STW, Reid JL (1997) Moxonidine: a review. Journal of Human Hypertension, 11, 629-635.
20. Zannad F (1994) Concomitant diseases in elderly hypertensives. Journal of Hypertension, 14, S37-S40.